Full Text
HPR28 Last Resort for Reimbursement of New Drugs in Germany: When the Arbitration Office Must Decide

Abstract

Authors

M Glüsen J Rehkopf A Martyniszyn-Eiben H Kielhorn-Schönermark M Schönermark

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×